ACID CONCENTRATE D12309 49.5 G — DIN 02244098
DEXTROSE : 49.5 G SODIUM CHLORIDE : 263 G MAGNESIUM CHLORIDE : 6.86 G CALCIUM CHLORIDE : 9.92 G POTASSIUM CHLORIDE : 3.35 G · BAXTER CORPORATION · LIQUID · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is ACID CONCENTRATE D12309?
ACID CONCENTRATE D12309 49.5 G contains DEXTROSE : 49.5 G SODIUM CHLORIDE : 263 G MAGNESIUM CHLORIDE : 6.86 G CALCIUM CHLORIDE : 9.92 G POTASSIUM CHLORIDE : 3.35 G. It is listed in the Health Canada Drug Product Database under DIN 02244098, held by BAXTER CORPORATION, supplied as LIQUID for HAEMODIALYSIS administration. Health Canada currently lists it as cancelled pre market, status dated 26-Jun-2025. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
Is there a generic Hemodialytics, Concentrates in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
22 holders have a Canadian DIN containing Hemodialytics, Concentrates, across 588 DINs, of which 117 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| VANTIVE ULC | 57 | 52 | ACID CONCENTRATE 2156, ACID CONCENTRATE 2182, ACID CONCENTRATE D12201, ACID CONCENTRATE D12207, ACID CONCENTRATE D12236, +51 more | Sourceable in Canada |
| CHIEF MEDICAL SUPPLIES LTD | 99 | 39 | ACID CONCENTRATE A1220, ACID CONCENTRATE A1221, ACID CONCENTRATE A1222, ACID CONCENTRATE A1223, ACID CONCENTRATE A1224, +75 more | Sourceable in Canada |
| FRESENIUS MEDICAL CARE RENAL THERAPIES GROUP, LLC | 34 | 18 | NATURALYTE H-200, NATURALYTE H-201, NATURALYTE H-206, NATURALYTE H-208, NATURALYTE H-225, +29 more | Sourceable in Canada |
| NXSTAGE MEDICAL INC | 8 | 6 | NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 303), NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 304), NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305), NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-301), NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-302), +3 more | Sourceable in Canada |
| FRESENIUS MEDICAL CARE CANADA INC | 12 | 2 | BIBAG, DELFLEX PERITONEAL DIALYSIS SOLUTION WITH 0.5% DEXTROSE, NATURALYTE H-202, NATURALYTE H-223, NATURALYTE H-224, +6 more | Sourceable in Canada |
| BAXTER CORPORATION | 108 | 0 | 800 SODIUM BICARBONATE POWDER, ACID CONCENTRATE 2100, ACID CONCENTRATE 2101, ACID CONCENTRATE 2102, ACID CONCENTRATE 2105, +95 more | No marketed DIN |
| GENPHARM ULC | 89 | 0 | ACID CONCENTRATE (R04146), ACID CONCENTRATE (R04938), ACID CONCENTRATE (R04968), ACID CONCENTRATE (R04969), ACID CONCENTRATE (R04974), +79 more | No marketed DIN |
| HAEMOTEC, A DIVISION OF FRESENIUS MEDICAL CARE CANADA INC. | 53 | 0 | CALCIUM CHLORIDE ADDITIVE 0.13-4.5L, H-629, H-700, H-701, H-702, +48 more | No marketed DIN |
| ALTHIN BIOPHARM INC. | 43 | 0 | ACID CONCENTRATE 2109, ACID CONCENTRATE 2165, ACID CONCENTRATE 2166, ACID CONCENTRATE 2168, ACID CONCENTRATE 2187, +38 more | No marketed DIN |
| BDH INC. | 22 | 0 | ACETATE CONCENTRATE R07318 LIQ, ACETATE CONCENTRATE R07376, ACID CONCENTRATE RX252C, ACID CONCENTRATE RX253C, ACID CONCENTRATE-R04948 LIQ, +17 more | No marketed DIN |
| BICARBOLYTE CORPORATION | 15 | 0 | BICARB HEMODIAL CONC 36.83, BICARB HEMODIAL CONC 36.83X ACID, BICARB HEMODIAL CONC 81.25GM/L, BICARBOLYTE BICAR HEMODIALSIS CONC, BICARBOLYTE BICAR HEMODIALYSIS CONC, +1 more | No marketed DIN |
| RENAL SYSTEMS, DIVISION OF MINNTECH CORP. | 15 | 0 | ACID HEMODIALYSIS CONC SB 1003, BC-I CONCENTRATE PWR, BICARBONATE CONC MB-330 PWR 650MG/PCK, RS-274, SB 1000, +10 more | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 49.5 G |
|---|---|
| Dosage form | LIQUID |
| Route | HAEMODIALYSIS |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Hemodialytics, Concentrates |
|---|---|
| ATC code | B05ZA |
| AHFS class | 40:34.00* ; See footnote |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02244098 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2244098 |
| Brand name | ACID CONCENTRATE D12309 |
| Generic / active ingredient | DEXTROSE : 49.5 G SODIUM CHLORIDE : 263 G MAGNESIUM CHLORIDE : 6.86 G CALCIUM CHLORIDE : 9.92 G POTASSIUM CHLORIDE : 3.35 G |
| Market authorization holder | BAXTER CORPORATION |
| Health Canada schedule | Ethical |
| ATC code | B05ZA |
| ATC anatomical main group | B — Blood and blood-forming organs |
| ATC therapeutic subgroup | B05ZA |
| Current status | CANCELLED PRE MARKET |
| Status date | 26-Jun-2025 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
117 of 588 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACID CONCENTRATE 2156 | 10.1 G | SOLUTION | VANTIVE ULC | MARKETED | 02239491 |
| ACID CONCENTRATE 2182 | 262.98 G | SOLUTION | VANTIVE ULC | MARKETED | 02210835 |
| ACID CONCENTRATE A1221 | 3.35 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | 02254344 |
| ACID CONCENTRATE A1222 | 263 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | 02254336 |
| ACID CONCENTRATE A1223 | 9.92 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | 02254328 |
| ACID CONCENTRATE A1224 | 263 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | 02254301 |
| ACID CONCENTRATE A1225 | 263.0 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | 02254298 |
| ACID CONCENTRATE A1226 | 49.5 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | 02254255 |
| ACID CONCENTRATE A1227 | 8.27 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | 02254247 |
| ACID CONCENTRATE A1228 | 49.5 G | SOLUTION | CHIEF MEDICAL SUPPLIES LTD | MARKETED | 02533774 |
2 · Same class — other molecules in ATC B05ZA
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Hemodialytics, Concentrates | 800 SODIUM BICARBONATE POWDER · ACETATE CONCENTRATE R07318 LIQ · ACETATE CONCENTRATE R07376 · ACID CONCENTRATE (R04146) · +538 more | 588 | 117 | Yes |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC B05Z
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| B05ZB | Hemofiltrates | 2 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.